Symposium on Blood Volume in Clinical MedicineBlood Volume Perturbations in the Postural Tachycardia Syndrome
Section snippets
Hypovolemia in the Postural Tachycardia Syndrome
Clinical research studies of patients with POTS have found patients with POTS to have low plasma volumes,12., 13. a low red cell volume,14., 15. or both.3
Fouad et al13 described a group of 11 patients with orthostatic intolerance in whom they found a marked reduction in blood volume without an obvious underlying cause. They labeled this phenomenon as “idiopathic hypovolemia.” These patients had a significant reduction in total blood volume (73% of the normal values for that laboratory) and
Blood Volume Regulation in the Postural Tachycardia Syndrome
The renin-angiotensin-aldosterone system plays a key role in the hormonal regulation of plasma volume in humans. Plasma renin activity (PRA) and angiotensin II should increase in response to hypovolemia to promote a corrective increase in blood volume.
Patients with orthostatic tachycardia who were also hypovolemic had low levels of standing PRA12 compared with normovolemic patients and control subjects. In a more recent study, the aldosterone level was lower in the patients with POTS in both
Treatment of Hypovolemia in the Postural Tachycardia Syndrome
Although hypovolemia in patients with POTS may be important for an understanding of the pathophysiology, there are scant data on the treatment of this problem once it has been discovered. In patients with a deficit in plasma volume, acute blood volume administration (or increase) has been shown to diminish the orthostatic tachycardia and improve symptoms. This has been shown using both intravenous albumin (50 mg per day × 3 days)13 and 1 liter of normal saline solution.21 On a chronic basis, we
Summary
Hypovolemia is a common finding in the postural tachycardia syndrome and may play an important underlying role in its pathophysiology. Abnormalities of both plasma volume and red cell volume have been noted. Further research is required to understand the exact nature of the blood volume dysregulation and to determine optimal treatment strategies.
References (21)
- et al.
Postural tachycardia syndrome: reversal of sympathetic hyperresponsiveness and clinical improvement during sodium loading
Am J Med
(1982) - et al.
Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system
Am J Med
(1997) - et al.
Treatment of orthostatic tachycardia with erythropoietin
Am J Med
(1995) - et al.
The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome
Am J Med Sci
(2000) - et al.
Enalapril-associated anemia in renal transplant recipients treated for hypertension
Am J Kidney Dis
(1991) - et al.
Postural tachycardia syndrome (POTS)
Neurology
(1995) - et al.
Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome
Circulation
(2005) - et al.
Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome
Circulation
(2005) - et al.
Correlates of functional disability in patients with postural tachycardia syndrome: preliminary cross-sectional findings
Health Psychol
(2003) The Postural Tachycardia Syndrome (POTS): pathophysiology, diagnosis and management
Indian Pacing Electrophysiol J
(2006)
Cited by (70)
Adrenal gland response to adrenocorticotropic hormone is intact in patients with postural orthostatic tachycardia syndrome
2023, Autonomic Neuroscience: Basic and ClinicalDistinct Hemodynamic Responses That Culminate With Postural Orthostatic Tachycardia Syndrome
2023, American Journal of CardiologyPostural orthostatic tachycardia syndrome: New concepts in pathophysiology and management
2023, Trends in Cardiovascular MedicineSelf-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review of observational and interventional studies
2023, Autonomic Neuroscience: Basic and ClinicalDizziness, Syncope, and Autonomic Dysfunction in Children
2022, Progress in Pediatric CardiologyPostural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1
2021, Autonomic Neuroscience: Basic and ClinicalCitation Excerpt :The hemodynamic properties of POTS identify closely with those seen in moderate hemorrhage in that central hypovolemia, reduced cardiac output, and increased adrenergic-mediated vasoconstriction occur (Fu et al., 2010; Stewart, 2012), while BP is maintained and may even increase (orthostatic hypertension) (Grubb et al., 1997). Reduced systemic venous return and reduced cardiac output contribute to reduced central blood volume when upright,(Barcroft et al., 1944) and absolute hypovolemia can be found (Fouad et al., 1986; Raj and Robertson, 2007; Raj et al., 2005) similar to bed-rested patients or astronauts with gravitational deconditioning (Montgomery et al., 1993). In others, redistributive central hypovolemia when upright occurs due to decreased lower extremity venous tone (Stewart and Montgomery, 2004), or splanchnic pooling (Stewart et al., 2006a).